ARCHIVES

CMS also decided to cover off-label uses of approved colorectal cancer drugs in clinical trials, and allowed broader use of PET scans.

This article is from The Cancer Letter archive.

Vol. 30 No. 42 | November 5, 2004

Download PDF Visit The Full Archive

Related Articles

AACR Statement on Precancers Plays Key Role in NCI Agenda

May 30, 2003

Tip O’Neill Testifies As Cancer Survivor At Hearing Called To Renew Commitment To ‘War On Cancer’

April 26, 1991

In Brief: Preyer, Waxman Battle Over Chairmanship Of Health Group; Amos To Head Mas. ACS

January 12, 1979

NCI-Approved Trials Listed

March 30, 2007

Funding Opportunities: RFAs For Mouse Models Consortium, Urology Research Centers

August 7, 1998

U.S. Adults close to Eating “5 A Day” Of Fruits, Vegetables

March 28, 1997